| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |